Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies
Pires da Silva, Ines, Glitza, Isabella C., Haydu, Lauren E., Johnpulle, Romany, Banks, Patricia D., Grass, George D., Goldinger, Simone M. A., Smith, Jessica L., Everett, Ashlyn S., Koelblinger, Peter, Roberts‐Thomson, Rachel, Millward, Michael, Atkinson, Victoria G., Guminski, Alexander, Kapoor, Rony, Conry, Robert M., Carlino, Matteo S., Wang, Wei, Shackleton, Mark J., Eroglu, Zeynep, Lo, Serigne, Hong, Angela M., Long, Georgina V., Johnson, Douglas B., Menzies, Alexander M.
Published in Pigment cell and melanoma research (01.07.2019)
Published in Pigment cell and melanoma research (01.07.2019)
Get full text
Journal Article
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Cebon, Jonathan, Jäger, Elke, Shackleton, Mark J, Gibbs, Peter, Davis, Ian D, Hopkins, Wendie, Gibbs, Sharen, Chen, Qiyuan, Karbach, Julia, Jackson, Heather, MacGregor, Duncan P, Sturrock, Sue, Vaughan, Hilary, Maraskovsky, Eugene, Neumann, Antje, Hoffman, Eric, Sherman, Mathew L, Knuth, Alexander
Published in Cancer immunity (16.07.2003)
Get full text
Published in Cancer immunity (16.07.2003)
Journal Article
Distinct mutational landscapes characterize melanomas metastatic to different anatomical sites
Iddawela, Mahesh Y., Kaplan, Benjamin G, Greenstein, Ray, Zhao, Peinan, Shackleton, Mark J., Huang, Richard S.P., Andrews, Miles Cameron
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
NADOM trial: Neoadjuvant/adjuvant trial of darovasertib in ocular melanoma (OM)
O'day, Roderick, Conway, Max, Lim, Li-Anne, McKenzie, John, Atkinson, Victoria, Glasson, William, McGrath, Lindsay, Cherepanoff, Svetlana, Gray, Elin, Maurer, Matthew A., O'Quigley, Michael, Shackleton, Mark J., Joshua, Anthony M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 2 safety and efficacy study of neoadjuvant/adjuvant darovasertib for localized ocular melanoma
Joshua, Anthony M., O'day, Roderick, Glasson, William, Sia, David, McGrath, Lindsay, Ameratunga, Malaka, Cosman, Rasha, Cherepanoff, Svetlana, O'Quigley, Michael, Beaupre, Darrin M., Conway, Max, Lim, Li-Anne, McKenzie, John, McKay, Daniel, Shackleton, Mark J., Fung, Adrian, Isaacs, Timothy, Yousif, Jacob, Brooks, Christine, Psaroulis, Trifon
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma
Lau, Peter Kar Han, Harris, Samuel John, Eastgate, Melissa A., Kee, Damien, Mant, Andrew, Nott, Louise M., Gedye, Craig, Inderjeeth, Andrisha Jade, Underhill, Craig, Weppler, Alison Margaret, Wallace, Roslyn, Lee, Belinda, Au-Yeung, George, Williams, Narelle, Ariza Ospino, Daniel, Gonzales, Louise, Shackleton, Mark J., Lo, Serigne N., McArthur, Grant A., Sandhu, Shahneen
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 1 dose-escalation study to investigate the safety, efficacy, pharmacokinetics, and pharmacodynamic activity of cln-619 (Anti-MICA/B antibody) alone and in combination with pembrolizumab in patients with advanced solid tumors
Wang, Judy S., Gutierrez, Martin, Rasco, Drew W., Melero Bermejo, Ignacio, Powderly, John D., Hamilton, Erika P., Millward, Michael, Arance, Ana Maria, Stec, Rafal, Moreno, Victor, Sharma, Manish, Lugowska, Iwona A., Shackleton, Mark J., Frentzas, Sophia, Janik, John Edward, Liu, Tracy, Shapiro, Irina, Whalen, Kerry, Jones, Jeffrey Alan, Spira, Alexander I.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 1 dose-escalation study to investigate the safety, efficacy, pharmacokinetics, and pharmacodynamic activity of CLN-619 (anti-MICA/MICB antibody) alone and in combination with pembrolizumab in patients with advanced solid tumors
Powderly, John D., Gutierrez, Martin, Wang, Judy S., Hamilton, Erika P., Sharma, Manish, Spira, Alexander I., Millward, Michael, Shackleton, Mark J., Frentzas, Sophia, Koczywas, Marianna, Mehta, Naveen, Christensen, Ann Marie, Shapiro, Irina, Whalen, Kerry, Michaelson, Jennifer, Baeuerle, Patrick, Janik, John Edward, Rasco, Drew W.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Stereotactic radiotherapy combined with immunotherapy is safe and effective: Results from a phase I clinical trial
Ratnayake, Gishan, Reinwald, Simone, Shackleton, Mark J., Moore, Maggie A., Voskoboynik, Mark, Ruben, Jeremy, Van Zelm, Menno, Yu, Di, Ward, Rachel, Smith, Robin, Haydon, Andrew Mark, Senthi, Sashendra
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma
Sayers, Louise, Lewin, Jeremy Howard, Kee, Damien, Walpole, Imogen, Sanelli, Alexandra, Herschtal, Alan, Spillane, John, Gyorki, David E., Speakman, David, Estall, Vanessa, Donahoe, Simon, Pohl, Miklos, Pope, Kathy, Chua, Margaret, Sandhu, Shahneen Kaur, McArthur, Grant A., McCormack, Christopher, Henderson, Michael A., Hicks, Rodney J, Shackleton, Mark J.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Incidence, features and management of radionecrosis (RN) in melanoma patients (pts) treated with cerebral radiotherapy (RT) and anti-PD-1 antibodies (PD1)
Pires Da Silva, Ines Esteves Domingues, Johnpulle, Romany Anne Nilanthi, Banks, Patricia Diana, Grass, G. Daniel, Smith, Jess Louise, Everett, Ashlyn S., Goldinger, Simone M., Roberts-Thomson, Rachel, Millward, Michael, Glitza, Isabella Claudia, Haydu, Lauren Elaine, Atkinson, Victoria, Wang, Tim, Eroglu, Zeynep, Conry, Robert Martin, Shackleton, Mark J., Hong, Angela, Long, Georgina V., Johnson, Douglas Buckner, Menzies, Alexander M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Surveillance imaging with FDG-PET in the follow-up of melanoma patients at high risk of relapse
Lewin, Jeremy Howard, Sanelli, Alexandra, Walpole, Imogen, Kee, Damien, Henderson, Michael A., Speakman, David, Spillane, John, Gyorki, David E., Estall, Vanessa, Te Marvelde, Luc, Pope, Kathy, Chua, Margaret, McArthur, Grant A., Hicks, Rodney J, Shackleton, Mark J.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma
Sandhu, Shahneen Kaur, Wong, Stephen Q, Vergara, Ismael A., Raleigh, Jeanette, Callahan, Jason, Ftouni, Sarah, Hatzimihalis, Athena, Devbarna, Sinha, Doig, Ken, Colebatch, Andrew, MirArnau, Gisela, Cullinane, Carleen, Gyorki, David E., Kee, Damien, Brady, Benjamin M., Shackleton, Mark J., Papenfuss, Anthony, Hicks, Rodney J, McArthur, Grant A., Dawson, Sarah-Jane
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Melanoma: do we need a hatchet or a scalpel?
Shackleton, Mark J, Quintana, Elsa, Fullen, Douglas R, Sabel, Michael S, Johnson, Timothy M
Published in Archives of dermatology (1960) (01.03.2009)
Published in Archives of dermatology (1960) (01.03.2009)
Get more information
Journal Article